Illumina Inc. (ILMN)

351.86
1.50 0.43
NASDAQ : Health Technology
Prev Close 350.37
Open 352.40
Day Low/High 350.98 / 354.25
52 Wk Low/High 196.00 / 357.93
Volume 107.54K
Avg Volume 899.90K
Exchange NASDAQ
Shares Outstanding 147.00M
Market Cap 51.58B
EPS 5.00
P/E Ratio 79.93
Div & Yield N.A. (N.A)

Latest News

Zuora's CEO Tells TheStreet Why He Still Sees a Lot of Room to Grow

Zuora's CEO Tells TheStreet Why He Still Sees a Lot of Room to Grow

The cloud software firm's shares are off sharply due to its guidance. However, CEO Tien Tzuo remains upbeat about the growth of his firm's addressable market.

Illumina To Webcast Upcoming Investor Conference Presentation

Illumina To Webcast Upcoming Investor Conference Presentation

Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference, and invited investors to participate via webcast.

Illumina Receives Approval Of MiSeq™Dx System In China

Illumina Receives Approval Of MiSeq™Dx System In China

Illumina, Inc. (NASDAQ:ILMN) today announced that its MiSeq™Dx Sequencing System received the approval certificate from the China National Drug Administration (CNDA).

Illumina Announces Pricing Of Convertible Senior Notes

Illumina Announces Pricing Of Convertible Senior Notes

Illumina, Inc. (Nasdaq: ILMN) today announced the pricing of an offering of $650 million aggregate principal amount of its 0.

Illumina To Offer $650 Million Convertible Senior Notes

Illumina To Offer $650 Million Convertible Senior Notes

Illumina, Inc. (Nasdaq: ILMN) today announced its intention to offer, subject to market and other conditions, approximately $650 million aggregate principal amount of convertible senior notes due 2023 (the "Notes").

Jim Cramer: 5 Sectors to Buy on This 'Turkish Contagion' Market Drop

Jim Cramer: 5 Sectors to Buy on This 'Turkish Contagion' Market Drop

It is all about perception, and here are strong names to pick up on market weakness.

Illumina Reports Financial Results For Second Quarter Of Fiscal Year 2018

Illumina Reports Financial Results For Second Quarter Of Fiscal Year 2018

Illumina, Inc. (NASDAQ:ILMN) today announced its financial results for the second quarter of fiscal year 2018.

Jim's Daily Rundown

Jim discusses his interview with Larry Kudlow at the Delivering Alpha conference, Nucor's earnings, Danaher's earnings and announced spin, Abbott Labs, and Comcast!

Biotech's Coming Back to Life: Cramer's 'Off the Charts'

Biotech's Coming Back to Life: Cramer's 'Off the Charts'

Some beaten up biotech names are finally coming back to life. Here's a look at the technical analysis.

Market Refuses To Go Lower: Cramer's 'Mad Money' Recap (Tuesday 7/17/18)

Market Refuses To Go Lower: Cramer's 'Mad Money' Recap (Tuesday 7/17/18)

Investors have never gone wrong buying Netflix on the dips. Jim Cramer tells you what to make of the 'FANG Musketeers.'

Illumina To Announce Second Quarter 2018 Financial Results On Monday, July 30, 2018

Illumina To Announce Second Quarter 2018 Financial Results On Monday, July 30, 2018

Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for second quarter 2018 following the close of market on Monday, July 30, 2018.

Illumina's Pullback Looks Like a Buying Opportunity for Further Gain

Illumina's Pullback Looks Like a Buying Opportunity for Further Gain

Look for gains in Illumina shares to $300 and then perhaps around $340.

Consider Going Long Illumina

Consider Going Long Illumina

Illumina could offer a profitable sequence.

Illumina To Webcast Upcoming Investor Conference Presentations

Illumina To Webcast Upcoming Investor Conference Presentations

Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conferences, and invited investors to participate via webcast.

Jim Cramer: Stocks That Do Well In a Declining Rate Environment Are Back

Jim Cramer: Stocks That Do Well In a Declining Rate Environment Are Back

The crash of oil will only accelerate the move.

Kaskela Law LLC Announces Investigation Of Illumina, Inc. On Behalf Of Stockholders

Kaskela Law LLC Announces Investigation Of Illumina, Inc. On Behalf Of Stockholders

Kaskela Law LLC has commenced an investigation of Illumina, Inc. ("Illumina" or the "Company") (Nasdaq: ILMN) on behalf of the Company's stockholders.

Illumina Acquires Edico Genome To Accelerate Genomic Data Analysis

Illumina Acquires Edico Genome To Accelerate Genomic Data Analysis

Illumina, Inc. (NASDAQ: ILMN) today announced that it acquired Edico Genome, the leading provider of data analysis acceleration solutions for next-generation sequencing (NGS).

Illumina To Webcast Upcoming Investor Conference Presentation

Illumina To Webcast Upcoming Investor Conference Presentation

Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference, and invites investors to participate via webcast.

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Breaches Of Fiduciary Duties By Management Of Illumina, Inc. - ILMN

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Breaches Of Fiduciary Duties By Management Of Illumina, Inc. - ILMN

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential breaches of fiduciary duties by management of Illumina, Inc.

Jim Cramer: Follow the Bouncing Equities

Jim Cramer: Follow the Bouncing Equities

Markets start day with a bungee jump.

Illumina Reports Financial Results For First Quarter Of Fiscal Year 2018

Illumina Reports Financial Results For First Quarter Of Fiscal Year 2018

Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the first quarter of fiscal year 2018.

Square Is One of 4 Upset Picks in Our Latest 'Sweet 16' Stock Selections

Square Is One of 4 Upset Picks in Our Latest 'Sweet 16' Stock Selections

Watch for these upstart names to topple some big-caps going forward.

Illumina To Webcast Upcoming Investor Conference Presentation

Illumina To Webcast Upcoming Investor Conference Presentation

Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference, and invites investors to participate via webcast.

Illumina Reports Financial Results For Fourth Quarter And Fiscal Year 2017

Illumina Reports Financial Results For Fourth Quarter And Fiscal Year 2017

Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the fourth quarter and fiscal year 2017.

Illumina Awarded $26.7M In Patent Suit Against Ariosa Diagnostics, Inc.

Illumina Awarded $26.7M In Patent Suit Against Ariosa Diagnostics, Inc.

Illumina, Inc. (NASDAQ: ILMN) announced today that a federal jury in San Francisco has ruled in its favor in a patent infringement suit filed against Ariosa Diagnostics, Inc.

Jim's Daily Rundown

In today's video, Jim discusses the government shutdown, an Eli Lilly downgrade, Schlumberger after Friday's earnings, and several other market-related topics.

TheStreet Quant Rating: B (Buy)